zytux™ 100 mg/10 ml concentrat pentru soluţie perfuzabilă
aryogen pharmed - rituximabum - concentrat pentru soluţie perfuzabilă - 100 mg/10 ml
zytux™ 500 mg/50 ml concentrat pentru soluţie perfuzabilă
aryogen pharmed - rituximabum - concentrat pentru soluţie perfuzabilă - 500 mg/50 ml
imatinib fair-med 100 mg
fair - imatinibum - compr. film. - 100mg - alte antineoplazice inhibitori de protein-kinaza
imatinib fair-med 400 mg
fair - imatinibum - compr. film. - 400mg - alte antineoplazice inhibitori de protein-kinaza
purevax rcp
boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.
purevax rcpch
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. incidența imunității a fost demonstrată la o săptămână după vaccinarea primară pentru rinotraheită, calicivirus, chlamydophila felis și componentele panleucopeniei. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rc
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.
mucosolvan 30 mg
boehringer ingelheim international gmbh - ambroxolum - compr. - 30mg - expectorante excl. combinatii cu antitusive mucolitice
imatinib amomed 100 mg
amomed pharma gmbh - imatinibum - compr. film. - 100mg - alte antineoplazice inhibitori de protein-kinaza
imatinib amomed 400 mg
amomed pharma gmbh - imatinibum - compr. film. - 400mg - alte antineoplazice inhibitori de protein-kinaza